• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

Leading Leicester researcher recognised by Academy of Medical Sciences

May 13, 2019

A respiratory consultant from Leicester’s Hospitals has been elected to join the prestigious Fellowship of the Academy of Medical Sciences.

Professor Chris Brightling, FMedSci

Christopher Brightling, who is also a professor of respiratory medicine at the University of Leicester, is among 50 of the UK’s world leading researchers to receive the distinction this year. The addition of Professor Brightling onto the roll brings the total number of Fellows from Leicester up to thirteen.

Professor Brightling leads the respiratory theme of the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, based at Glenfield Hospital. His research interests include investigating the role of Fevipiprant, a non-steroidal asthma medicine, on the reduction of smooth muscle in the airways. He is also working on refining a urine test that can alert patients with chronic obstructive pulmonary disease (COPD) when they are likely to have an exacerbation of their symptoms.

Professor Brightling said: “I feel honoured to be recognised among this prestigious group of people, many of whom have had a big impact on me throughout my career. I would like to thank the members of the Fellowship who supported my nomination, and all the members of the research team from the hospital and university in Leicester for their hard work towards our goal of improving respiratory health in our patients.”

The new Fellows have been elected for their outstanding contributions to biomedical and health science, leading research discoveries, and translating developments into benefits for patients and the wider society. They are also recognised for their leadership and for supporting the career advancement of junior trainees.

This year’s elected Fellows have expertise that spans global health, virology, women’s health, medical statistics, health policy, cancer genetics, allergy and emergency care medicine, among many other fields.

Professor Sir Robert Lechler PMedSci, President of the Academy of Medical Sciences said: “The Academy’s Fellowship is a unique assembly of the finest minds in biomedical and health research, from across the UK and beyond. Our Fellows are at the centre of all that we do, from supporting early career researchers via our hugely popular mentorship programme to incorporating public and patient views into health research. Their collective wisdom is a national asset to guide research and policy aimed at tackling pressing health challenges.

“It brings me great pleasure to congratulate the new Fellows, each of whom has pushed the boundaries of their individual research field. I am always delighted to see the Fellowship expand, adding fresh talent to our invaluable pool of high quality guidance, advice and expertise.”

Professor Philippa Saunders FRSE FMedSci, Registrar of the Academy of Medical Sciences, said: “The Academy continues to ensure that the diversity of medical science is represented in the Fellowship. This year we are particularly pleased to celebrate the highest percentage of women the Academy has ever elected in one year, taking us a step closer to our goal of gender parity.

“Nineteen of the new Fellows are women, representing 38 per cent of all Fellows elected in 2019, the highest percentage of women ever elected in one year. Twenty per cent of the new Fellows are non-UK nationals, coming from seven countries and four continents. We are pleased that this year’s election figures take us closer to a more equal Fellowship with regards to the number of men to women Fellows, and have an international spread. The Academy is committed to working towards diversity and equality of opportunity in everything we do.”

The new Fellows will be formally admitted to the Academy at a ceremony on 26 June 2019.

Ends

Category: Press Releases

Recent News

Leicester health specialists receive NIHR prizes for excelling in their fields

Respiratory researcher awarded Asthma + Lung UK Junior Fellowship

Weight-loss drug users turn to social media over doctors for advice

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}